Cargando…

Benefits of Inactivated Vaccine and Viral Vector Vaccine Immunization on COVID-19 Infection in Kidney Transplant Recipients

The coronavirus virus disease 2019 (COVID-19) pandemic has impacted the global healthcare system. In Thailand, the first and most available vaccines were inactivated and viral vector vaccines. We reported the impact of those vaccines in preventing severe disease and death in kidney transplant recipi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sutharattanapong, Napun, Thotsiri, Sansanee, Kantachuvesiri, Surasak, Wiwattanathum, Punlop
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031304/ https://www.ncbi.nlm.nih.gov/pubmed/35455322 http://dx.doi.org/10.3390/vaccines10040572

Ejemplares similares

The Effect of a Booster Dose mRNA Vaccine on COVID-19 Infection in Kidney Transplant Recipients after Inactivated or Viral Vector Vaccine Immunization
por: Thotsiri, Sansanee, et al.
Publicado: (2022)

Stabilization of estimated glomerular filtration rate in kidney transplantation from deceased donors with acute kidney injuries
por: Wiwattanathum, Punlop, et al.
Publicado: (2016)

A 46-Year-Old Thai Woman with Secondary Acquired Pure Red Cell Aplasia Due to Treatment with Recombinant Erythropoietin While on Dialysis for End-Stage Renal Disease Who Recovered Following ABO-Incompatible Kidney Transplantation
por: Kitpermkiat, Rungthiwa, et al.
Publicado: (2022)

SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study)
por: Bruminhent, Jackrapong, et al.
Publicado: (2022)

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2022)

A Nationwide Survey of Cytomegalovirus Prevention Strategies in Kidney Transplant Recipients in a Resource-Limited Setting
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity
por: Kirisri, Similan, et al.
Publicado: (2021)

1198. Measurement of Pre-transplant Anti-cytomegalovirus (CMV) Immunoglobulin G Titer to Predict Risk of CMV Infection in CMV-seropositive Kidney Transplant Recipients
por: Kirisri, Similan, et al.
Publicado: (2020)

BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

Impact of Carbapenem Peri-Transplant Prophylaxis and Risk of Extended-Spectrum Cephalosporin-Resistant Enterobacterales Early Urinary Tract Infection in Kidney Transplant Recipients: A Propensity Score-Matched Analysis
por: Aramwittayanukul, Suwadee, et al.
Publicado: (2022)

Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients
por: Zhang, Lei, et al.
Publicado: (2023)

Guidelines for vaccination in kidney transplant recipients
Publicado: (2016)

Heterologous regimen viral-vector/mRNA produces significantly higher SARS-CoV-2 humoral response than homologous viral-vector and inactivated vaccines in liver transplant recipients
por: Mendizabal, Manuel, et al.
Publicado: (2022)

509. Role of cell-mediated immune monitoring using Interferon-γ Enzyme-linked Immunosorbent Spot Assay to predict CMV infection within six months after kidney transplantation
por: Namsiripongpan, Warunyu, et al.
Publicado: (2022)

COVID-19 vaccination in kidney transplant recipients
por: Caillard, Sophie, et al.
Publicado: (2021)

1189. Correlation of BK polyomavirus (BKPyV)-specific Immunity and BKPyV Viruria within 6 months after Kidney Transplantation: A Prospective Cohort Study
por: Siripoon, Tanaya, et al.
Publicado: (2020)

Inactivated Viral Vaccines
por: Sanders, Barbara, et al.
Publicado: (2014)

Immunogenicity profiling and distinct immune response in liver transplant recipients vaccinated with SARS-CoV-2 inactivated vaccines
por: Duan, Binwei, et al.
Publicado: (2022)

Evaluating the Response and Safety of Inactivated COVID-19 Vaccines in Liver Transplant Recipients
por: Tu, Zhen-Hua, et al.
Publicado: (2022)

Vaccinations in kidney transplant recipients: Clearing the muddy waters
por: Arora, Swati, et al.
Publicado: (2019)

COVID-19 Vaccination in Kidney Transplant Candidates and Recipients
por: Ponticelli, Claudio, et al.
Publicado: (2022)

1075 Effectiveness and Safety of Immunization with Live-attenuated and Inactivated Vaccines for Pediatric Liver Transplantation Recipients
por: Ito, Yoshinori, et al.
Publicado: (2014)

1749. A Nationwide Survey of Cytomegalovirus Prevention Strategies in Kidney Transplant Recipients in a Resource-Limited Setting
por: Bruminhent, Jackrapong, et al.
Publicado: (2019)

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
por: Kanokudom, Sitthichai, et al.
Publicado: (2022)

A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney transplant recipient patients
por: Chen, Sikai, et al.
Publicado: (2023)

Viral vector vaccines
por: McCann, Naina, et al.
Publicado: (2022)

Common viral infections in kidney transplant recipients
por: Vanichanan, Jakapat, et al.
Publicado: (2018)

Viral seroprevalence in pediatric kidney transplant recipients
por: Aksoy, Gülşah Kaya, et al.
Publicado: (2020)

Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients
por: Kared, Hassen, et al.
Publicado: (2023)

Safety and Efficacy of the COVID-19 Vaccine in Kidney Transplant Recipients
por: Altheaby, Abdulrahman, et al.
Publicado: (2022)

COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients
por: Zhang, Xiaojing, et al.
Publicado: (2022)

Clinical and immunological characteristics for BK polyomavirus‐associated nephropathy after kidney transplantation
por: Siripoon, Tanaya, et al.
Publicado: (2023)

Perioperative hemoglobin decrement as an independent risk of poor early graft function in kidney transplantation
por: Chutipongtanate, Arpa, et al.
Publicado: (2020)

Declined Humoral Immunity of Kidney Transplant Recipients to SARS-CoV-2 Vaccines
por: Mahallawi, Waleed H, et al.
Publicado: (2023)

Immune Profile Determines Response to Vaccination against COVID-19 in Kidney Transplant Recipients
por: Stai, Stamatia, et al.
Publicado: (2023)

Blood unconjugated bilirubin and tacrolimus are negative predictors of specific cellular immunity in kidney transplant recipients after SAR-CoV-2 inactivated vaccination
por: Zhang, Lei, et al.
Publicado: (2023)

POS-817 COVID-19 INFECTION AND VACCINATION IN KIDNEY TRANSPLANT RECIPIENTS
por: TAY, L.L., et al.
Publicado: (2022)

SARS-CoV-2 vaccine strategies in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2023)

Viral vectors for vaccine applications
por: Choi, Youngjoo, et al.
Publicado: (2013)

Viral Vectors for Veterinary Vaccines
por: Sheppard, Michael
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_0hmieo2uve9pccqtphf6lnjro1